Clinical Trial Update: PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring a PD-1 inhibitor combined with neoadjuvant chemotherapy in resectable locally advanced thoracic esophageal squamous cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Neoplasms
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN